Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network, discusses how partnerships help community practices achieve growth.
Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network (AON), discusses how partnerships help community practices achieve growth.
Transcript
How are partnerships playing a role in achieving growth for community practices, and what value can this add?
Partnerships are critical for smaller practices because I think it’s become so difficult, especially just with the high cost of drugs. Remember, these practices have to spend often times hundreds of thousands of dollars on drugs, put them in their inventory and then hopefully get paid for it after you treat a patient. You might not get paid for 30, 60, 90 days later. In our case, we take that burden away from the practice to have to deal with the cash flow, the negative cash flow of buying the drugs and hoping to get paid.
We’re doing a lot of the backend services, whether its revenue cycle, purchasing, information technology, legal, accounting, finance. So, having the ability to offer those services allows physicians to focus on what’s really important and also gives these practices at the local level the best chance for continuing to keep their doors open.
Typically, 80% of a practice’s expenses are drug related, and with the ever-increasing cost of drugs, they’re being pressed; the margins are shrinking. So, it’s more and more difficult for these practices to remain successful, whereas when they join an organization like AON, we’re bringing them an improved margin on their drugs, we’re giving them access to services they don’t have today, whether it’s laboratory, pathology, specialty pharmacy, they’re a part of the Oncology Care Model. These are things that we bring value, not only financially but equally if not more important clinically.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More